HRTX Heron Therapeutics, Inc. - Common Stock
$0,31
Prezzo · Ago 18, 2026
Fondamentali al Ago 10, 2026
Intervallo 52 sett.
$0–$2
1% of range
Rating Analisti
BUY
8 analysts
Prezzo Obiettivo
$2
+549% upside
P/E (TTM)
-2.6
ROE
312.5%
Margine di Profitto Netto
-13.0%
HRTX Snapshot del titolo Prezzo, capitalizzazione di mercato, P/E, EPS, ROE, debito/capitale proprio, intervallo 52 settimane
Prezzo
$0.31
Capitalizzazione di Mercato
$58M
P/E (TTM)
-2.6
EPS (TTM)
$-0.12
Ricavi (TTM)
$155M
Rendimento div.
—
ROE
312.5%
D/E Debito/Patrimonio
—
Intervallo 52 sett.
$0 – $2
HRTX Grafico del prezzo delle azioni OHLCV giornaliero con indicatori tecnici — panoramica, zoom e personalizza la tua visualizzazione
Configure
Performance decennale Andamento di ricavi, utile netto, margini e EPS
Ricavi e Utile Netto
$155M
2016-12-31
→
2025-12-31
EPS
$-0.12
2021-12-31
→
2025-12-31
Flusso di cassa libero
$-28M
2016-12-31
→
2025-12-31
Margini
-13.0%
2023-12-31
→
2025-12-31
Valutazione Rapporti P/E, P/S, P/B, EV/EBITDA — il titolo è costoso o economico?
Metrica
Tendenza 5 anni
HRTX
Mediana dei peer
P/E (TTM)
-2.6
—
P/S (TTM)
0.4
165.8
P/B
4.1
1.6
Price / FCF (Prezzo / FCF)
-2.1
—
Redditività Margini lordi, operativi e netti; ROE, ROA, ROIC
Metrica
Tendenza 5 anni
HRTX
Mediana dei peer
Gross Margin (Margine lordo)
73.3%
71.1%
Operating Margin (Margine Operativo)
-1.6%
—
Net Profit Margin (Margine di Profitto Netto)
-13.0%
-2229.6%
ROA
-8.3%
-64.3%
ROE
312.5%
-102.1%
Salute finanziaria Debito, liquidità, solvibilità — solidità del bilancio
Metrica
Tendenza 5 anni
HRTX
Mediana dei peer
Current Ratio (Rapporto corrente)
2.5
4.8
Quick Ratio
1.2
—
Crescita Crescita di ricavi, EPS e utile netto: YoY, CAGR 3Y, CAGR 5Y
Metrica
Tendenza 5 anni
HRTX
Mediana dei peer
Revenue YoY (Ricavi YoY)
7.4%
—
Revenue CAGR 3Y (CAGR Ricavi 3Y)
12.9%
—
Revenue CAGR 5Y (CAGR Ricavi 5Y)
11.8%
—
Efficienza del Capitale Rotazione delle attività, rotazione delle scorte, rotazione dei crediti
Metrica
Tendenza 5 anni
HRTX
Mediana dei peer
HRTX Consenso degli analisti Opinioni degli analisti, sia rialziste che ribassiste, target price a 12 mesi, potenziale di rialzo
COMPRA
8 analisti
- Acquisto forte 2 25,0%
- Compra 4 50,0%
- Mantieni 2 25,0%
- Vendi 0 0,0%
- Vendita forte 0 0,0%
Target Price a 12 Mesi
1 analisti · 2026-08-13
Basso
$2.00
Alto
$2.00
Target mediano
$2.00
+548,5%
Target medio
$2.00
+548,5%
Cronologia utili EPS effettivo vs stima, surprise %, tasso di superamento, data prossimi utili
Sorpresa media
-0.01%
| Periodo | EPS Actual | EPS Stimato | Sorpresa |
|---|---|---|---|
| 30 Giugno 2026 | $-0.03 | $0.01 | -0.04% |
| 31 Marzo 2026 | $-0.04 | $-0.02 | -0.02% |
| 31 Dicembre 2025 | $-0.02 | $-0.02 | 0.00% |
| 30 Settembre 2025 | $-0.04 | $-0.02 | -0.02% |
| 30 Giugno 2025 | $-0.02 | $-0.01 | -0.01% |
| 31 Marzo 2025 | $0.01 | $-0.01 | 0.02% |
Confronto Peer (GICS sub-settore industriale) Metriche chiave rispetto ai pari del settore
| Ticker | Capitalizzazione di Mercato | P/E | Rev YoY | Margine Netto | ROE | Margine lordo |
|---|---|---|---|---|---|---|
| HRTX | $245M | -10.8 | 7.4% | -13.0% | 312.5% | 73.3% |
| TENX | $114M | -9.1 | — | — | -52.5% | — |
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | — |
| MNOV | $64M | -5.5 | — | -2928.8% | -27.1% | — |
| BOLD | $27M | -0.5 | — | — | -46.7% | — |
| INMB | $41M | -0.8 | 257.1% | -91866.0% | -175.3% | — |
| EXOZ | $92M | -10.0 | — | — | -172.3% | — |
| INKT | — | -3.8 | 4.5% | -6931.8% | 63.4% | — |
| CLNN | $64M | — | -41.5% | -13086.5% | 200.2% | — |
| RNXT | — | -2.6 | 2511.6% | — | — | — |
Fondamentali Completi Tutte le metriche per anno — conto economico, stato patrimoniale, rendiconto finanziario
Conto Economico 17
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $155M | $144M | $127M | $108M | $86M | $89M | $146M | $77M | $31M | $1M | |
| Cost of Revenue | $41M | $39M | $65M | $55M | $46M | $36M | $62M | $28M | $5M | $35.0K | |
| Gross Profit | $114M | $106M | $62M | $53M | · | · | · | · | · | · | |
| R&D Expense | $12M | $17M | $39M | $83M | $131M | $175M | $167M | $140M | $139M | $103M | |
| SG&A Expense | $55M | $53M | $66M | $62M | $40M | $42M | $38M | $29M | $26M | $21M | |
| Operating Expenses | $116M | $117M | $173M | $227M | $304M | $317M | $357M | $261M | $225M | $172M | |
| Operating Income | $-3M | $-12M | $-111M | $-175M | $-218M | $-228M | $-211M | $-184M | $-195M | $-171M | |
| Interest Expense | · | · | $4M | $2M | $2M | $2M | $1M | $3M | $4M | $3M | |
| Interest Income | $2M | $4M | $3M | $2M | $433.0K | $4M | $7M | $6M | $1M | $445.0K | |
| Other Non-op | $1M | $430.0K | $560.0K | $-7M | $-878.0K | $-847.0K | $158.0K | $2M | $-38.0K | $-9.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-20M | $-14M | $-111M | $-182M | $-221M | $-227M | $-205M | $-179M | $-197M | $-173M | |
| EPS (Basic) | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 | · | · | · | · | · | |
| EPS (Diluted) | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 | · | · | · | · | · | |
| Shares (Basic) | 166,707,000 | 152,449,000 | 138,135,000 | 108,876,000 | 98,471 | · | · | · | · | · | |
| Shares (Diluted) | 166,707,000 | 152,449,000 | 138,135,000 | 108,876,000 | 98,471 | · | · | · | · | · | |
| EBITDA | $-224.0K | $-9M | $-108M | $-172M | $-215M | $-225M | $-209M | $-182M | $-193M | $-171M |
Stato Patrimoniale 23
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $29M | $26M | $29M | $15M | $91M | $105M | $72M | $32M | $145M | $13M | |
| Short-term Investments | · | · | · | · | · | · | · | $301M | $28M | $38M | |
| Receivables | $90M | $79M | $60M | $52M | $35M | $42M | $40M | $65M | $42M | $2M | |
| Inventory | $93M | $53M | $42M | $55M | $48M | $42M | $25M | $39M | $10M | $5M | |
| Prepaid Expense | $9M | $18M | $6M | $14M | $13M | $22M | $23M | $11M | $4M | $4M | |
| Current Assets | $238M | $209M | $189M | $205M | $254M | $314M | $479M | $447M | $228M | $62M | |
| PP&E (Net) | $12M | $15M | $20M | $22M | $24M | $23M | $20M | $15M | $6M | $5M | |
| PP&E (Gross) | $25M | $33M | $37M | $36M | $37M | $34M | $28M | $23M | $14M | $12M | |
| Accum. Depreciation | $13M | $18M | $17M | $14M | $13M | $11M | $8M | $8M | $8M | $7M | |
| Other Non-current Assets | $5M | $6M | $8M | $16M | $18M | $346.0K | $346.0K | $254.0K | $263.0K | $263.0K | |
| Total Assets | $256M | $233M | $223M | $251M | $306M | $354M | $513M | $462M | $234M | $67M | |
| Accounts Payable | $9M | $12M | $3M | $3M | $4M | $525.0K | $3M | $17M | $19M | $7M | |
| Current Liabilities | $96M | $91M | $80M | $82M | $71M | $103M | $97M | $92M | $103M | $39M | |
| Capital Leases | $0 | · | $3M | $5M | $8M | $15M | $12M | · | · | · | |
| Other Non-current Liabilities | $5M | $615.0K | $241.0K | $241.0K | · | · | · | · | · | · | |
| Total Liabilities | $242M | $267M | $256M | $237M | $228M | $117M | $109M | $92M | $103M | $89M | |
| Common Stock | $2M | $2M | $2M | $1M | $1M | $913.0K | $903.0K | $782.0K | $646.0K | $394.0K | |
| Paid-in Capital | $1.95B | $1.88B | $1.87B | $1.81B | $1.69B | $1.63B | $1.57B | $1.33B | $914M | $564M | |
| Retained Earnings | $-1.94B | $-1.92B | $-1.91B | $-1.80B | $-1.61B | $-1.39B | $-1.17B | $-961M | $-783M | $-586M | |
| AOCI | $4.0K | $13.0K | $13.0K | $-19.0K | $-6.0K | $257.0K | $85.0K | $-87.0K | $-10.0K | $-17.0K | |
| Stockholders' Equity | $14M | $-34M | $-34M | $14M | $78M | $236M | $404M | $370M | $131M | $-21M | |
| Liabilities + Equity | $256M | $233M | $223M | $251M | $306M | $354M | $513M | $462M | $234M | $67M | |
| Shares Outstanding | 188,314,430 | 152,127,878 | 150,285,044 | 119,154,538 | 102,005,000 | 91,310,000 | 90,304,000 | 78,174,000 | 64,609,000 | 39,355 |
Flusso di cassa 13
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $1M | |
| Stock-based Comp | $10M | $13M | $33M | $43M | $47M | $50M | $51M | $33M | $31M | $26M | |
| Restructuring | · | · | · | · | · | $6M | · | · | · | · | |
| Other Non-cash | $-20M | $-24M | $16M | $-11M | $-33M | $-11M | $27M | $-48M | $-5M | · | |
| Operating Cash Flow | $-28M | $-23M | $-59M | $-147M | $-203M | $-185M | $-125M | $-192M | $-170M | $-134M | |
| CapEx | $317.0K | $2M | $2M | $2M | $3M | $7M | $7M | $9M | $3M | $3M | |
| Investing Cash Flow | $16M | $19M | $18M | $-3M | $33M | $209M | $-22M | $-279M | $8M | $15M | |
| Net Debt Issued | · | · | · | · | · | · | · | $-25M | $-25M | · | |
| Stock Issued | $18M | · | $30M | $75M | · | · | $162M | $363M | $306M | · | |
| Net Stock Activity | $18M | · | $30M | $75M | · | · | $162M | · | · | · | |
| Financing Cash Flow | $14M | $940.0K | $54M | $75M | $156M | $9M | $186M | $358M | $294M | $57M | |
| Net Change in Cash | $3M | $-3M | $13M | $-75M | $-15M | $33M | $40M | $-113M | $131M | $-62M | |
| Free Cash Flow | $-28M | $-24M | $-60M | $-149M | $-206M | $-192M | $-132M | $-201M | $-173M | $-137M |
Redditività 6
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 73.3% | 73.2% | 48.8% | · | · | · | · | · | · | · | |
| Operating Margin | -1.6% | -8.0% | -87.1% | -162.2% | -252.3% | -257.4% | -144.3% | -237.4% | -632.4% | -13363.2% | |
| Net Margin | -13.0% | -9.4% | -87.0% | -169.0% | -255.6% | -256.4% | -140.3% | -230.8% | -641.9% | -13537.4% | |
| EBITDA Margin | -0.14% | -6.3% | -84.8% | -159.5% | -248.8% | -254.2% | -142.9% | -235.5% | -627.4% | -13363.2% | |
| ROA | -8.3% | -6.0% | -46.7% | -65.4% | -67.0% | -52.5% | -42.0% | -51.3% | -130.9% | -168.7% | |
| ROE | 312.5% | 36.9% | 358.0% | -1010.6% | -224.7% | -88.5% | -59.4% | -46.0% | -359.4% | -357.5% |
Liquidità e Solvibilità 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.3 | 2.4 | 2.5 | 3.6 | 3.1 | 5.0 | 4.9 | 2.2 | 1.6 | |
| Quick Ratio | 1.2 | 1.1 | 1.1 | 0.8 | 1.8 | 1.4 | 1.2 | 4.3 | 2.1 | 1.4 | |
| Interest Coverage | · | · | -28.6 | -70.6 | -90.4 | -120.0 | -143.1 | -68.8 | -49.4 | -64.2 |
Efficienza 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.6 | 0.6 | 0.5 | 0.4 | 0.3 | 0.2 | 0.3 | 0.2 | 0.2 | 0.0 | |
| Inventory Turnover | 0.6 | 0.8 | 1.3 | 1.1 | 1.0 | 1.1 | 1.9 | 1.1 | 0.6 | 0.0 | |
| Receivables Turnover | 1.8 | 2.1 | 2.3 | 2.5 | 2.2 | 2.2 | 2.8 | 1.5 | 1.4 | 1.3 |
Tassi di Crescita 3
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 7.4% | 13.6% | 18.0% | 24.7% | -2.6% | · | · | · | · | · | |
| Revenue CAGR 3Y | 12.9% | 18.7% | 12.8% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 11.8% | · | · | · | · | · | · | · | · | · |
Valutazione (TTM) 10
| Metrica | Tendenza | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $155M | $144M | $127M | $108M | $86M | $89M | $146M | $77M | $31M | $1M | |
| Net Income TTM | $-20M | $-14M | $-111M | $-182M | $-221M | $-227M | $-205M | $-179M | $-197M | $-173M | |
| Market Cap | $245M | $233M | $255M | $298M | $931M | $1.93B | $2.12B | $2.03B | $1M | $516M | |
| P/E | -10.8 | -17.0 | -2.1 | -1.5 | -4.1 | · | · | · | · | · | |
| P/S | 1.6 | 1.6 | 2.0 | 2.8 | 10.8 | 21.8 | 14.5 | 26.2 | 0.0 | 403.1 | |
| P/B | 17.1 | -6.9 | -7.5 | 21.9 | 12.0 | 8.2 | 5.3 | 5.5 | 0.0 | -24.3 | |
| P / Tangible Book | 17.1 | · | · | 21.9 | 12.0 | 8.2 | · | · | · | · | |
| P / Cash Flow | -8.9 | -10.3 | -4.3 | -2.0 | -4.6 | -10.5 | -17.0 | -10.6 | -0.0 | -3.8 | |
| P / FCF | -8.8 | -9.6 | -4.2 | -2.0 | -4.5 | -10.1 | -16.1 | -10.1 | -0.0 | -3.8 | |
| Earnings Yield | -9.2% | -5.9% | -47.1% | -66.8% | -24.5% | · | · | · | · | · |
Conto Economico 14
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $38M | $35M | $41M | $38M | $37M | $39M | $41M | $33M | $36M | $35M | $34M | $31M | $32M | $30M | $30M | $27M | |
| Cost of Revenue | $12M | $11M | $11M | $12M | $10M | $8M | $10M | $9M | $11M | $8M | $10M | $18M | $20M | $17M | $13M | $15M | |
| Gross Profit | $26M | $24M | $29M | $26M | $27M | $30M | $31M | $23M | $26M | $26M | $24M | $13M | $12M | $13M | $17M | $12M | |
| R&D Expense | $3M | $2M | $4M | $3M | $3M | $2M | $3M | $4M | $4M | $5M | $8M | $9M | $13M | $9M | $-14M | $26M | |
| SG&A Expense | $11M | $12M | $13M | $14M | $14M | $13M | $12M | $12M | $14M | $15M | $14M | $16M | $20M | $16M | $34M | $10M | |
| Operating Expenses | $28M | $29M | $29M | $30M | $29M | $27M | $26M | $28M | $32M | $31M | $35M | $38M | $54M | $46M | $10M | $54M | |
| Operating Income | $-2M | $-5M | $38.0K | $-4M | $-2M | $3M | $4M | $-4M | $-6M | $-5M | $-10M | $-25M | $-42M | $-33M | $-20M | $-42M | |
| Other Non-op | $-3M | $-3M | $5M | $-2M | $-744.0K | $-519.0K | $2M | $-390.0K | $-3M | $2M | $0 | $-79.0K | $344.0K | $295.0K | $1M | $-26.0K | |
| Net Income | $-5M | $-8M | $-3M | $-17M | $-2M | $3M | $4M | $-5M | $-9M | $-3M | $-11M | $-25M | $-42M | $-33M | $-20M | $-42M | |
| EPS (Basic) | $-0.03 | $-0.04 | $-0.02 | $-0.10 | $-0.02 | $0.02 | $0.02 | $-0.03 | $-0.06 | $-0.02 | $-0.01 | $-0.17 | $-0.35 | $-0.27 | $-0.11 | $-0.38 | |
| EPS (Diluted) | $-0.03 | $-0.04 | $-0.01 | $-0.10 | $-0.02 | $0.01 | $0.02 | $-0.03 | $-0.06 | $-0.02 | $-0.01 | $-0.17 | $-0.35 | $-0.27 | $-0.11 | $-0.38 | |
| Shares (Basic) | 190,335,000 | 189,646,000 | -311,151,000 | 170,348,000 | 154,020,000 | 153,490,000 | -303,885,000 | 152,830,000 | 152,305,000 | 151,199,000 | -245,820,000 | 144,990,000 | 119,719,000 | 119,246,000 | -207,387,000 | 111,735,000 | |
| Shares (Diluted) | 190,335,000 | 189,646,000 | -354,582,000 | 170,348,000 | 154,020,000 | 196,921,000 | -303,885,000 | 152,830,000 | 152,305,000 | 151,199,000 | -245,820,000 | 144,990,000 | 119,719,000 | 119,246,000 | -207,387,000 | 111,735,000 | |
| EBITDA | $-2M | $-4M | · | $-4M | $-2M | $4M | · | $-4M | $-6M | $-4M | · | $-25M | $-42M | $-32M | · | $-42M |
Stato Patrimoniale 22
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $21M | $26M | $29M | $43M | $17M | $19M | $26M | $26M | $18M | $20M | · | $35M | $13M | $27M | · | $50M | |
| Receivables | $90M | $84M | $90M | $81M | $80M | $79M | $79M | $67M | $74M | $65M | · | $64M | $77M | $51M | · | $42M | |
| Inventory | $91M | $93M | $93M | $70M | $73M | $57M | $53M | $46M | $43M | $42M | · | $42M | $45M | $52M | · | $52M | |
| Prepaid Expense | $7M | $8M | $9M | $23M | $17M | $26M | $18M | $11M | $7M | $7M | · | $11M | $11M | $15M | · | $8M | |
| Current Assets | $230M | $229M | $238M | $229M | $211M | $213M | $209M | $195M | $191M | $186M | · | $194M | $165M | $178M | · | $224M | |
| PP&E (Net) | $12M | $12M | $12M | $13M | $14M | $15M | $15M | $15M | $16M | $19M | · | $21M | $21M | $22M | · | $23M | |
| PP&E (Gross) | · | · | $25M | · | · | · | $33M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $13M | · | · | · | $18M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $5M | $5M | $5M | $6M | $6M | $6M | $6M | $7M | $7M | $8M | · | $8M | $9M | $14M | · | $17M | |
| Total Assets | $252M | $246M | $256M | $249M | $232M | $236M | $233M | $221M | $218M | $218M | · | $229M | $201M | $221M | · | $272M | |
| Accounts Payable | $12M | $9M | $9M | $12M | $12M | $12M | $12M | $10M | $10M | $837.0K | · | $2M | $2M | $4M | · | $7M | |
| Current Liabilities | $92M | $91M | $96M | $90M | $259M | $89M | $91M | $86M | $80M | $75M | · | $80M | $87M | $78M | · | $94M | |
| Capital Leases | $6M | · | · | · | · | · | · | $522.0K | $1M | $2M | · | $4M | $4M | $5M | · | $6M | |
| Other Non-current Liabilities | $5M | $5M | $5M | $5M | $747.0K | $682.0K | $615.0K | $241.0K | $241.0K | $241.0K | · | $241.0K | $241.0K | $241.0K | · | $241.0K | |
| Total Liabilities | $245M | $237M | $242M | $234M | $259M | $264M | $267M | $261M | $256M | $252M | · | $257M | $241M | $232M | · | $250M | |
| Common Stock | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $1M | $1M | $1M | · | $1M | |
| Paid-in Capital | $1.96B | $1.95B | $1.95B | $1.94B | $1.89B | $1.89B | $1.88B | $1.88B | $1.88B | $1.87B | · | $1.87B | $1.83B | $1.82B | · | $1.80B | |
| Retained Earnings | $-1.95B | $-1.95B | $-1.94B | $-1.94B | $-1.92B | $-1.92B | $-1.92B | $-1.92B | $-1.92B | $-1.91B | · | $-1.90B | $-1.87B | $-1.83B | · | $-1.78B | |
| AOCI | $-6.0K | $-6.0K | $4.0K | $0 | $-1.0K | $1.0K | $13.0K | $40.0K | $-8.0K | $-6.0K | · | $-1.0K | $-6.0K | $9.0K | · | $-57.0K | |
| Stockholders' Equity | $7M | $9M | $14M | $15M | $-27M | $-28M | $-34M | $-40M | $-38M | $-34M | $-34M | $-28M | $-39M | $-11M | $14M | $22M | |
| Liabilities + Equity | $252M | $246M | $256M | $249M | $232M | $236M | $233M | $221M | $218M | $218M | · | $229M | $201M | $221M | · | $272M | |
| Shares Outstanding | · | · | 188,314,430 | · | · | · | 152,127,878 | · | · | · | · | · | · | · | · | · |
Flusso di cassa 10
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $452.0K | $529.0K | $537.0K | $615.0K | $611.0K | $551.0K | $581.0K | $581.0K | $641.0K | $689.0K | $715.0K | $727.0K | $739.0K | $718.0K | $791.0K | $706.0K | |
| Stock-based Comp | $3M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $5M | $3M | $4M | $7M | $14M | $8M | $11M | $11M | |
| Other Non-cash | · | $3M | · | · | · | $-15M | · | · | · | $-10M | · | · | · | $-797.0K | · | · | |
| Operating Cash Flow | $-2M | $-2M | $-9M | $1M | $-11M | $-9M | $-12M | $3M | $-5M | $-10M | $2M | $-9M | $-27M | $-25M | $-38M | $-37M | |
| CapEx | $138.0K | $391.0K | $0 | $0 | $208.0K | $109.0K | $638.0K | $431.0K | · | · | $250.0K | $793.0K | $278.0K | $224.0K | $414.0K | $45.0K | |
| Investing Cash Flow | $-3M | $-939.0K | $-5M | $12M | $7M | $2M | $11M | $4M | $2M | $1M | $-9M | $-23M | $13M | $37M | $2M | $-36M | |
| Stock Issued | · | · | $-2M | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $82.0K | $-51.0K | $219.0K | $13M | $781.0K | $64.0K | $423.0K | $14.0K | $492.0K | $11.0K | $199.0K | $54M | $319.0K | $-208.0K | $439.0K | $75M | |
| Net Change in Cash | $-5M | $-3M | $-14M | $27M | $-3M | $-7M | $61.0K | $7M | $-2M | $-8M | $-6M | $21M | $-14M | $12M | $-35M | $2M | |
| Free Cash Flow | · | $-2M | · | · | · | $-9M | · | · | · | · | · | · | · | $-25M | · | · |
Redditività 6
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 69.3% | 69.3% | · | 68.8% | 73.5% | 78.3% | · | 71.2% | 70.8% | 75.6% | · | 42.1% | · | · | · | · | |
| Operating Margin | -5.4% | -13.7% | · | -10.7% | -4.4% | 8.1% | · | -13.6% | -17.9% | -13.8% | · | -79.3% | -133.5% | -111.6% | · | -157.7% | |
| Net Margin | -14.6% | -23.4% | · | -45.8% | -6.4% | 6.8% | · | -14.8% | -25.6% | -9.1% | · | -79.6% | -132.4% | -110.7% | · | -157.8% | |
| EBITDA Margin | -5.4% | -12.2% | · | -10.7% | -4.4% | 9.5% | · | -13.6% | -17.9% | -11.8% | · | -79.3% | -133.5% | -109.2% | · | -157.7% | |
| ROA | -2.3% | -3.4% | · | -7.4% | -1.1% | 1.2% | · | -2.1% | -4.4% | -1.4% | · | -10.0% | -18.9% | -13.2% | · | -13.4% | |
| ROE | 53.9% | 84.0% | · | 139.3% | 7.3% | -8.5% | · | 14.3% | 23.9% | 14.0% | · | 937.3% | 137.8% | -523.1% | · | -59.3% |
Liquidità e Solvibilità 2
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.5 | · | 2.6 | 0.8 | 2.4 | · | 2.3 | 2.4 | 2.5 | · | 2.4 | 1.9 | 2.3 | · | 2.4 | |
| Quick Ratio | 1.2 | 1.2 | · | 1.4 | 0.4 | 1.1 | · | 1.1 | 1.1 | 1.1 | · | 1.2 | 1.0 | 1.0 | · | 1.0 |
Efficienza 3
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.1 | 0.2 | 0.2 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | |
| Inventory Turnover | 0.1 | 0.1 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.4 | 0.4 | 0.3 | · | 0.3 | |
| Receivables Turnover | 0.4 | 0.4 | · | 0.5 | 0.5 | 0.5 | · | 0.5 | 0.5 | 0.6 | · | 0.6 | 0.5 | 0.6 | · | 0.6 |
Valutazione (TTM) 4
| Metrica | Tendenza | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $148M | $149M | · | $147M | $145M | $142M | · | $135M | $134M | $127M | · | $119M | $116M | $107M | · | $101M | |
| Net Income TTM | $-33M | $-25M | · | $-22M | $-14M | $-15M | · | $-42M | $-79M | $-103M | · | $-142M | $-173M | $-195M | · | $-215M | |
| P/E | -2.3 | -5.3 | · | -9.0 | -20.7 | -22.0 | · | -7.1 | -5.8 | -3.4 | · | -0.9 | -0.7 | -0.8 | · | -2.0 | |
| Earnings Yield | -44.2% | -18.8% | · | -11.1% | -4.8% | -4.5% | · | -14.1% | -17.1% | -29.2% | · | -113.6% | -133.6% | -121.2% | · | -49.0% |
Bilanci Conto economico, stato patrimoniale, flusso di cassa — annuale, ultimi 5 anni
Conto Economico
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Ricavi | $155M | $144M | $127M | $108M | $86M |
| Margine Lordo % | 73.3% | 73.2% | 48.8% | — | — |
| Margine Operativo % | -1.6% | -8.0% | -87.1% | -162.2% | -252.3% |
| Utile netto | $-20M | $-14M | $-111M | $-182M | $-221M |
| EPS Diluito | $-0.12 | $-0.09 | $-0.80 | $-1.67 | $-2.24 |
Stato Patrimoniale
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Rapporto corrente | 2.5 | 2.3 | 2.4 | 2.5 | 3.6 |
| Quick Ratio | 1.2 | 1.1 | 1.1 | 0.8 | 1.8 |
Flusso di cassa
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Flusso di cassa libero | $-28M | $-24M | $-60M | $-149M | $-206M |
Ultime notizie Notizie recenti che menzionano questa società
Le Mie Metriche La tua watchlist personale — righe selezionate da Fondamentali Completi
📊
Scegli le metriche che contano per te — fai clic sul ➕ accanto a qualsiasi riga nei Fondamentali Completi sopra.
La tua selezione è salvata e ti segue su tutti i ticker.
Proprietari istituzionali (13F) 184 filer · $51.8M totale · Aggiornato al 30 Giugno 2026
Istituzioni che segnalano il possesso di questo titolo nel loro Modulo SEC 13F trimestrale. Solo posizioni lunghe; un singolo depositante può apparire due volte per diverse gambe di opzioni. Grandi posizioni put/call contrapposte riflettono tipicamente market-making o inventario coperto, non convinzione direzionale.
Attività istituzionale — Q2 2026 vs trimestre precedente
| Nuove posizioni | Posizioni chiuse | Aumentato | Diminuito | Variazione netta delle azioni |
|---|---|---|---|---|
| 25 (-7 vs trimestre precedente) | 21 (-6 vs trimestre precedente) | 50 (+3 vs trimestre precedente) | 40 (-6 vs trimestre precedente) | -15.3M |
Confrontato con Q1 2026. Le dichiarazioni SEC Form 13F sono dovute entro 45 giorni dalla fine del trimestre più un breve margine per i dichiaranti in ritardo — i trimestri ancora all'interno di questa finestra vengono saltati a favore della coppia più recente completamente riportata.
| Istituzione | Valore | Azioni | % di 13F tracciati | Tipo |
|---|---|---|---|---|
| Rubric Capital Management LP | $12.823.986 | 30.046.828 | 24,76% | Azioni |
| Clearline Capital LP | $4.858.675 | 11.383.961 | 9,38% | Azioni |
| Velan Capital Investment Management LP | $3.735.904 | 8.753.290 | 7,21% | Azioni |
| VANGUARD CAPITAL MANAGEMENT LLC | $3.323.230 | 7.782.741 | 6,42% | Azioni |
| Tejara Capital Ltd | $2.778.807 | 6.510.795 | 5,36% | Azioni |
| TANG CAPITAL MANAGEMENT LLC | $2.667.500 | 6.250.000 | 5,15% | Azioni |
| MILLENNIUM MANAGEMENT LLC | $1.737.119 | 4.070.101 | 3,35% | Azioni |
| JW Asset Management, LLC | $1.600.958 | 3.751.073 | 3,09% | Azioni |
| GEODE CAPITAL MANAGEMENT, LLC | $1.543.336 | 3.614.773 | 2,98% | Azioni |
| VANGUARD GROUP INC | $1.500.729 | 1.154.407 | 2,90% | Azioni |
| Stonepine Capital Management, LLC | $1.500.000 | 1.000.000 | 2,90% | Opzione Call |
| STATE STREET CORP | $1.377.948 | 3.228.557 | 2,66% | Azioni |
| Pale Fire Capital SE | $1.071.899 | 2.511.478 | 2,07% | Azioni |
| Caption Management, LLC | $896.280 | 2.100.000 | 1,73% | Opzione Put |
| Congress Park Capital LLC | $860.620 | 2.016.447 | 1,66% | Azioni |
| TWO SIGMA ADVISERS, LP | $675.442 | 519.571 | 1,30% | Azioni |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $674.878 | 1.580.510 | 1,30% | Azioni |
| RENAISSANCE TECHNOLOGIES LLC | $643.145 | 1.506.900 | 1,24% | Azioni |
| VANGUARD FIDUCIARY TRUST CO | $582.906 | 1.365.119 | 1,13% | Azioni |
| PANAGORA ASSET MANAGEMENT INC | $547.071 | 1.281.796 | 1,06% | Azioni |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $519.613 | 1.217.463 | 1,00% | Azioni |
| Qube Research & Technologies Ltd | $435.802 | 1.021.092 | 0,84% | Azioni |
| Caption Management, LLC | $426.800 | 1.000.000 | 0,82% | Azioni |
| CM Management, LLC | $426.800 | 1.000.000 | 0,82% | Azioni |
| NEW YORK STATE COMMON RETIREMENT FUND | $296.270 | 694.165 | 0,57% | Azioni |
| ALLIANCEBERNSTEIN L.P. | $239.958 | 299.910 | 0,46% | Azioni |
| Stonepine Capital Management, LLC | $209.468 | 490.787 | 0,40% | Azioni |
| DIADEMA PARTNERS LP | $195.783 | 458.723 | 0,38% | Azioni |
| Xcelsior Advisor Partners LLC | $173.186 | 405.777 | 0,33% | Azioni |
| Apeiron RIA LLC | $158.163 | 370.579 | 0,31% | Azioni |
| Squarepoint Ops LLC | $137.078 | 321.177 | 0,26% | Azioni |
| Integrated Wealth Concepts LLC | $136.107 | 318.903 | 0,26% | Azioni |
| Glenmede Investment Management, LP | $132.710 | 105.326 | 0,26% | Azioni |
| Richmond Brothers, Inc. | $131.755 | 308.706 | 0,25% | Azioni |
| TWO SIGMA INVESTMENTS, LP | $113.663 | 266.314 | 0,22% | Azioni |
| MARSHALL WACE, LLP | $105.194 | 244.638 | 0,20% | Azioni |
| NEXPOINT ASSET MANAGEMENT, L.P. | $99.359 | 232.800 | 0,19% | Azioni |
| FMR LLC | $96.800 | 226.803 | 0,19% | Azioni |
| Abel Hall, LLC | $90.987 | 213.185 | 0,18% | Azioni |
| CAROLINAS WEALTH CONSULTING LLC | $90.983 | 41.356 | 0,18% | Azioni |
| Horan Securities, Inc. | $86.091 | 41.590 | 0,17% | Azioni |
| RHUMBLINE ADVISERS | $83.482 | 195.537 | 0,16% | Azioni |
| Cutter & CO Brokerage, Inc. | $80.223 | 36.465 | 0,15% | Azioni |
| Quinn Opportunity Partners LLC | $74.837 | 175.344 | 0,14% | Azioni |
| GOLDMAN SACHS GROUP INC | $74.770 | 175.188 | 0,14% | Azioni |
| DLK Investment Management, LLC | $62.615 | 17.890 | 0,12% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $58.500 | 137.067 | 0,11% | Azioni |
| Bank of New York Mellon Corp | $54.073 | 126.693 | 0,10% | Azioni |
| D. E. Shaw & Co., Inc. | $51.402 | 120.435 | 0,10% | Azioni |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $51.341 | 120.293 | 0,10% | Azioni |
| Persistent Asset Partners Ltd | $49.974 | 117.090 | 0,10% | Azioni |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48.289 | 112.300 | 0,09% | Opzione Call |
| BANK OF AMERICA CORP /DE/ | $46.165 | 108.369 | 0,09% | Azioni |
| Redwood Family Wealth LLC | $45.015 | 105.472 | 0,09% | Azioni |
| Biltmore Family Office, LLC | $42.680 | 100.000 | 0,08% | Azioni |
| DEUTSCHE BANK AG\ | $41.409 | 96.300 | 0,08% | Azioni |
| IEQ CAPITAL, LLC | $41.234 | 96.612 | 0,08% | Azioni |
| BARCLAYS PLC | $37.172 | 87.094 | 0,07% | Azioni |
| SEARLE & CO. | $36.812 | 86.250 | 0,07% | Azioni |
| Vanguard Global Advisers, LLC | $35.764 | 83.756 | 0,07% | Azioni |
| BlackRock, Inc. | $35.761 | 83.788 | 0,07% | Azioni |
| Russell Investments Group, Ltd. | $34.675 | 81.246 | 0,07% | Azioni |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $31.406 | 73.585 | 0,06% | Azioni |
| MERCER GLOBAL ADVISORS INC /ADV | $29.147 | 68.291 | 0,06% | Azioni |
| CITIGROUP INC | $28.050 | 65.721 | 0,05% | Azioni |
| Invesco Ltd. | $27.051 | 63.382 | 0,05% | Azioni |
| LPL Financial LLC | $26.083 | 61.112 | 0,05% | Azioni |
| COMMONWEALTH EQUITY SERVICES, LLC | $25.254 | 59.176 | 0,05% | Azioni |
| Anfield Capital Management, LLC | $24.003 | 30.000 | 0,05% | Azioni |
| Mariner, LLC | $23.896 | 55.972 | 0,05% | Azioni |
| NICOLET ADVISORY SERVICES, LLC | $23.840 | 16.000 | 0,05% | Azioni |
| Chicago Partners Investment Group LLC | $23.526 | 51.254 | 0,05% | Azioni |
| CWM, LLC | $23.115 | 28.890 | 0,04% | Azioni |
| Cerity Partners LLC | $22.473 | 52.654 | 0,04% | Azioni |
| CAPTRUST FINANCIAL ADVISORS | $22.000 | 51.547 | 0,04% | Azioni |
| RAYMOND JAMES FINANCIAL INC | $20.003 | 46.868 | 0,04% | Azioni |
| R Squared Ltd | $19.935 | 46.708 | 0,04% | Azioni |
| Centiva Capital, LP | $19.422 | 45.507 | 0,04% | Azioni |
| Nuveen Asset Management, LLC | $19.408 | 12.685 | 0,04% | Azioni |
| INTECH INVESTMENT MANAGEMENT LLC | $17.990 | 42.150 | 0,03% | Azioni |
| HORAN Wealth, LLC | $17.751 | 41.590 | 0,03% | Azioni |
| Prospera Financial Services Inc | $17.308 | 40.565 | 0,03% | Azioni |
| Cornerstone Select Advisors, LLC | $17.057 | 39.964 | 0,03% | Azioni |
| NEUBERGER BERMAN GROUP LLC | $16.647 | 38.987 | 0,03% | Azioni |
| Police & Firemen's Retirement System of New Jersey | $16.369 | 38.352 | 0,03% | Azioni |
| GROUP ONE TRADING LLC | $16.196 | 37.947 | 0,03% | Azioni |
| Creative Planning | $15.306 | 35.862 | 0,03% | Azioni |
| Tower Research Capital LLC (TRC) | $15.180 | 35.567 | 0,03% | Azioni |
| HSBC HOLDINGS PLC | $14.464 | 33.381 | 0,03% | Azioni |
| DDFG, Inc | $14.043 | 32.903 | 0,03% | Azioni |
| Concurrent Investment Advisors, LLC | $13.625 | 31.923 | 0,03% | Azioni |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | $13.425 | 32.397 | 0,03% | Azioni |
| CIBC WORLD MARKETS CORP | $13.215 | 10.165 | 0,03% | Azioni |
| Skopos Labs, Inc. | $12.744 | 15.927 | 0,02% | Azioni |
| CoreCap Advisors, LLC | $12.125 | 28.409 | 0,02% | Azioni |
| Vanguard Personalized Indexing Management, LLC | $11.641 | 27.276 | 0,02% | Azioni |
| DIVERSIFIED TRUST CO | $11.306 | 26.492 | 0,02% | Azioni |
| CITADEL ADVISORS LLC | $11.139 | 26.100 | 0,02% | Opzione Call |
| Pallas Capital Advisors LLC | $10.968 | 25.699 | 0,02% | Azioni |
| JANE STREET GROUP, LLC | $10.957 | 25.672 | 0,02% | Azioni |
Insider aziendali 39 insider · 21 dirigenti · 21 direttori
| Insider | Ruolo | Ultima attività | Azioni possedute | Acquisti 12m | Vendite 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Craig A Collard | Chief Executive Officer | 31 Luglio 2026 M | 856.492 | 0 | 0 | $0 |
| Barry D Quart | Chief Executive Officer | 18 Gennaio 2023 A | 177.989 | 0 | 0 | $0 |
| Ronald J Prentki | President & CEO | 17 Febbraio 2010 A | 40.539 | 0 | 0 | $0 |
| Michael Oconnell | Chief Executive Officer | 10 Gennaio 2006 A | 132.200 | 0 | 0 | $0 |
| Ira Duarte | EVP, Chief Financial Officer | 31 Luglio 2026 M | 281.899 | 0 | 0 | $0 |
| Robert Hoffman | CFO & SVP, Finance | 19 Dicembre 2019 A | 1.280 | 0 | 0 | $0 |
| Brian G. Drazba | VP, Finance & CFO | 31 Ottobre 2016 J | 3.798 | 0 | 0 | $0 |
| John Whelan | CFO | 18 Luglio 2013 M | 254.088 | 0 | 0 | $0 |
| Stephen Whiteford | V.P., Finance & CFO | 15 Dicembre 2006 A | 15.000 | 0 | 0 | $0 |
| John Poyhonen | President & CCO | 13 Aprile 2023 M | 46.648 | 0 | 0 | $0 |
| Robert Rosen | President | 15 Dicembre 2018 A | 2.640 | 0 | 0 | $0 |
| David Leslie Szekeres | EVP, Chief Operating Officer | 13 Luglio 2023 M | 33.754 | 0 | 0 | $0 |
| Michael A Adam | Chief Operating Officer | 08 Febbraio 2013 A | — | 0 | 0 | $0 |
| William P Forbes | EVP, Chief Development Officer | 31 Luglio 2026 M | 241.173 | 0 | 0 | $0 |
| Lisa Peraza | VP, Chief Accounting Officer | 19 Gennaio 2024 A | 55.907 | 0 | 0 | $0 |
| Kimberly Manhard | EVP, Drug Development | 13 Aprile 2023 M | 28.330 | 0 | 0 | $0 |
| Marshall Paul | SVP, Technical Operations | 21 Marzo 2016 M | 2.200 | 0 | 0 | $0 |
| Neil James Clendeninn | SVP & Chief Medical Officer | 12 Ottobre 2015 A | — | 0 | 0 | $0 |
| Mark S. Gelder MD | SVP & Chief Medical Officer | 12 Dicembre 2014 A | — | 0 | 0 | $0 |
| John Barr | Vice President of R&D | 08 Luglio 2011 A | 51.772 | 0 | 0 | $0 |
| Anastassios D. Retzios | VP of Clinical Development | 15 Gennaio 2008 A | — | 0 | 0 | $0 |
| Thomas Cusack | Direttore | 30 Gennaio 2026 A | 53.960 | 0 | 0 | $0 |
| Morgan Adam | Direttore | 30 Gennaio 2026 A | 123.737 | 0 | 0 | $0 |
| Sharmila Dissanaike | Direttore | 30 Gennaio 2026 A | 53.960 | 0 | 0 | $0 |
| Michael Kaseta | Direttore | 30 Gennaio 2026 A | 53.960 | 0 | 0 | $0 |
| Waage Christian | Direttore | 30 Gennaio 2026 A | 53.960 | 0 | 0 | $0 |
| Craig A Johnson | Direttore | 30 Gennaio 2026 A | 53.960 | 0 | 0 | $0 |
| Susan Rodriguez | Direttore | 31 Gennaio 2025 A | 87.180 | 0 | 0 | $0 |
| Stephen Davis | Direttore | 16 Dicembre 2022 A | 52.032 | 0 | 0 | $0 |
| KEVIN TANG | Direttore | 19 Dicembre 2019 A | 5.799.810 | 0 | 0 | $0 |
| Greg Turnbull | Direttore | 29 Maggio 2012 A | 245.092 | 0 | 0 | $0 |
| Paul Goddard | Direttore | 29 Maggio 2012 A | 214.683 | 0 | 0 | $0 |
| Toby Rosenblatt | Direttore | 20 Maggio 2010 A | 210.234 | 0 | 0 | $0 |
| Robert L Zerbe MD | Direttore | 20 Maggio 2010 A | 202.072 | 0 | 0 | $0 |
| Peter Riepenhausen | Direttore | 28 Maggio 2008 A | 9.000 | 0 | 0 | $0 |
| Arthur T Taylor | Direttore | 28 Maggio 2008 A | 12.000 | 0 | 0 | $0 |
| Dennis L Winger | Direttore | 11 Agosto 2006 A | 69.544 | 0 | 0 | $0 |
| Stephen A Drury | Direttore | 11 Agosto 2006 J | 83.283 | 0 | 0 | $0 |
| Mark Earl Hensley | — | 06 Agosto 2026 M | 170.901 | 0 | 0 | $0 |
Insider dai depositi SEC Modulo 3/4/5; netto = solo acquisti/vendite di mercato
Attivisti e proprietari del 5%+ 3 partecipazioni
Investitori che hanno depositato SEC Schedule 13D — proprietà effettiva superiore al 5% con l'intento di influenzare l'emittente (partecipazioni attiviste, campagne per il consiglio di amministrazione, M&A). Ogni riga mostra lo stato più recente noto della posizione di quel depositante.
| Depositante | Depositato | Partecipazione | Stato | Scopo | Deposito |
|---|---|---|---|---|---|
| Rubric Capital Management LP, David Rosen ×6 depositi | 17 Ottobre 2025 | 15,90% | Modifica | — | SEC |
| Tang Capital Partners, LP, Tang Capital Management, LLC, Kevin Tang ×20 depositi | 07 Gennaio 2020 | — | Deposito iniziale | — | SEC |
| Felix J. Baker, Julian C. Baker ×3 depositi | 07 Luglio 2011 | — | Deposito iniziale | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Proprietà ETF Posseduti da 22 ETF
Il peso riflette solo le partecipazioni azionarie dirette (N-PORT); fondi a leva o basati su derivati possono detenere ulteriore esposizione swap non mostrata.
| Fondo | Peso | Unità | Aggiornato al | Fonte |
|---|---|---|---|---|
| QQQS · Invesco Exchange-Traded Fund Trust … | 0,28% | 128.515 SH | 08 Agosto 2026 | Giornaliero |
| IWC · iShares Trust | 0,02% | 537.335 SH | 08 Agosto 2026 | Giornaliero |
| RSSL · Global X Funds | 0,01% | 67.617 NS | 30 Aprile 2026 | N-PORT |
| IWO · iShares Trust | 0,00% | 1.328.289 SH | 08 Agosto 2026 | Giornaliero |
| ITWO · ProShares Trust | 0,00% | 7.231 NS | 31 Maggio 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,00% | 198.683 SH | 08 Agosto 2026 | Giornaliero |
| SCHA · SCHWAB STRATEGIC TRUST | 0,00% | 869.904 NS | 31 Maggio 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 3.609.893 SH | 08 Agosto 2026 | Giornaliero |
| UWM · ProShares Trust | 0,00% | 5.655 NS | 31 Maggio 2026 | N-PORT |
| IWN · iShares Trust | 0,00% | 505.371 SH | 08 Agosto 2026 | Giornaliero |
| URTY · ProShares Trust | 0,00% | 5.714 NS | 31 Maggio 2026 | N-PORT |
| HDG · ProShares Trust | 0,00% | 144 NS | 31 Maggio 2026 | N-PORT |
| MSSM · MORGAN STANLEY PATHWAY FUNDS | 0,00% | 4.190 NS | 31 Maggio 2026 | N-PORT |
| SCHB · SCHWAB STRATEGIC TRUST | 0,00% | 83.361 NS | 31 Maggio 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 28.626 SH | 08 Agosto 2026 | Giornaliero |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 2.063.361 SH | 08 Agosto 2026 | Giornaliero |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 5.474.947 SH | 08 Agosto 2026 | Giornaliero |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 925.988 SH | 08 Agosto 2026 | Giornaliero |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,00% | 13.208 SH | 08 Agosto 2026 | Giornaliero |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 156.616 SH | 08 Agosto 2026 | Giornaliero |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 12.513 SH | 08 Agosto 2026 | Giornaliero |
| VHT · VANGUARD WORLD FUND | 0,00% | 472.185 SH | 08 Agosto 2026 | Giornaliero |